Karen Drexler is Director of RESMED INC. Currently has a direct ownership of 8,446 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Apr 29, 2024, when has been sold 425 shares (ResMed Common Stock) at a price of $214.92 per share, resulting in proceeds of $91,341. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.45K
0% 3M change
5.75% 12M change
Total Value Held $0

Karen Drexler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 29 2024
SELL
Open market or private sale
$91,341 $214.92 p/Share
425 Reduced 4.79%
8,446 ResMed Common Stock
Nov 16 2023
BUY
Grant, award, or other acquisition
-
884 Added 9.06%
8,871 ResMed Common Stock
Feb 02 2023
SELL
Open market or private sale
$134,588 $226.58 p/Share
594 Reduced 6.92%
7,987 ResMed Common Stock
Nov 16 2022
BUY
Grant, award, or other acquisition
-
1,122 Added 11.56%
8,581 ResMed Common Stock
Nov 18 2021
BUY
Grant, award, or other acquisition
-
478 Added 6.02%
7,459 ResMed Common Stock
Nov 19 2020
BUY
Grant, award, or other acquisition
-
594 Added 7.84%
6,981 ResMed Common Stock

Also insider at

OM
Outset Medical, Inc. Healthcare
TIVC
Tivic Health Systems, Inc. Healthcare
KD

Karen Drexler

Director
South San Francisco, CA

Track Institutional and Insider Activities on RSMDF

Follow RESMED INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

News

Receive news related to RESMED INC

Track Activities on RSMDF